Les projets que nous finançons (uniquement en anglais)

The Program will fund research that leverages Australia's existing strengths in prostate cancer biomedical research to deliver outcomes that can be translated into clinical practice within the next 5 to 7 years.

This project uses a mass market, multi dimensional campaigns to shift populations understanding, attitudes and intentions and ultimately improve health outcomes on a large scale. Focusing on Youth Mental Health we will be working in partnership with PBS to deliver a documentary series supported with educational, digital and in person elements delivered across the USA.

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across ten countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across ten countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across ten countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across ten countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across ten countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across ten countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across ten countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across 15 countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across 15 countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

Clinician Scientist Awards aim to support outstanding, clinically qualified professionals who have gained a PhD in health research, to combine their clinical career with a research career and establish themselves as independent researchers in the field of prostate cancer.

Established in 2017 and operating across 17 countries, the TrueNTH Global Registry is an international project that aims to improve the physical and mental health of men with prostate cancer. Clinicians and hospitals contributing data to TrueNTH Global Registry receive regular, risk-adjusted reports on their patients’ health outcomes as compared to other clinicians and hospitals globally. This will support improvement in clinical practice and patient outcomes over time.

To support the implementation of outside the box proof of concept ideas that disrupt long held assumptions/myths about men and their health which will encourage doing things differently and ultimately lead to improved health outcomes.

The Prostate Cancer Outcomes Registry of Australia and New Zealand (PCOR-ANZ) is a clinical quality registry collecting data on the diagnosis, clinical care and outcomes for men living with prostate cancer across Australia and New Zealand.

TrueNTH Testicular Cancer is a website, optimised for mobile devices, that aims to bring resources to men who are facing a diagnosis and early treatment for testicular cancer. We have created a resource that delivers information to men to help them navigate the early stages of treatment along with the functionality to connect with a survivor who has lived through the same experience to facilitate peer support and a capacity to seek advice from experts in the field relating to the Testicular Cancer Journey.